Fatty Liver Disease: When Are Lifestyle Changes Enough, and When Do You Need Medication?
Fatty liver disease is no longer a rare condition - it is the most common liver disease in the world, affecting roughly one-third of the global population. Often progressing silently without noticeable symptoms, it can eventually lead to severe complications such as cirrhosis and liver cancer.
According to Dr. Tarek Saadi, Director of the Liver Unit at Rambam Health Care Campus, understanding the risk factors, early diagnosis, and knowing when to transition from lifestyle modifications to innovative drug treatments can save lives.

The Silent Disease: What Is Fatty Liver?
Fatty liver disease occurs when fat accumulates inside liver cells. "If more than 5% of liver cells contain fat, it is already considered fatty liver," explains Dr. Saadi. "It is a disease in its own right, and it has become more common than any other liver disease we know."
Despite its high prevalence, the disease is notoriously quiet in its early stages. Most patients feel completely fine, leading to delayed diagnoses typically discovered only through routine blood tests (elevated liver enzymes) or imaging. While some patients may experience mild fatigue, weakness, or slight discomfort in the upper right abdomen, these symptoms are rarely dramatic enough to prompt immediate medical investigation.
Main Risk Factors
The four primary drivers of fatty liver disease are:
Abdominal obesity
Diabetes
High blood pressure
Elevated blood lipids (cholesterol/triglycerides)
Anyone with a BMI over 25 (and especially over 30), or those managing diabetes, should be closely monitored.
From Simple Fat Accumulation to Inflammation (MASH)
In advanced cases, fat accumulation can trigger active inflammation known as MASH (Metabolic dysfunction-Associated SteatoHepatitis).
If left unchecked, MASH can cause liver scarring (fibrosis), which progresses through several histological stages:
Grade 0:Â No fibrosis
Grade 1:Â Mild fibrosis
Grade 2:Â Moderate fibrosis
Grade 3:Â Advanced fibrosis
Grade 4:Â Cirrhosis

As fibrosis advances, the risk of life-threatening complications skyrockets - including fluid accumulation in the abdomen (ascites), esophageal variceal bleeding, hepatic encephalopathy (brain confusion), and an increased risk of liver cancer.
Fortunately, invasive biopsies are often no longer required to assess liver stiffness and fat content. Doctors now utilize FibroScan - a painless, ultrasound-like test available at specialized centers like Rambam’s Liver Unit.
Treatment Pillar 1: Lifestyle Changes & Bariatric Surgery
The first line of defense remains lifestyle modification. Dr. Saadi emphasizes that weight loss, regular physical activity, proper nutrition, and balancing blood sugar, cholesterol, and blood pressure have the most profound impact on the disease's trajectory.
However, sustaining drastic lifestyle changes over the long term is notoriously difficult for many patients. While bariatric surgery serves as a viable option for certain individuals, recent years have ushered in an exciting new pharmaceutical frontier.

A Major Breakthrough: GLP-1 Receptor Agonists and the ESSENCEÂ Study
In a landmark milestone for hepatology, the U.S. Food and Drug Administration (FDA) approved Wegovy (semaglutide) - a popular weight-loss medication - for the treatment of adult patients with MASH and moderate-to-advanced liver fibrosis (stages F2-F3), without cirrhosis.
This historic approval is based on the robust ESSENCE Phase 3 clinical trial, which followed more than 1,200 patients and was published in the New England Journal of Medicine. The study’s findings demonstrated that Wegovy effectively treats metabolic-associated fatty liver disease, yielding remarkable results after 72 weeks of treatment:
Fibrosis Improvement: 36.8% of patients treated with Wegovy achieved an improvement in liver fibrosis without worsening of steatohepatitis, compared to 22.4% in the placebo group.
Resolution of Inflammation: 62.9% achieved complete resolution of MASH inflammation, compared to 34.3% in the placebo group.
"This is the first time we have a medication that produces proven histological improvement in both inflammation and scarring of the liver," notes Dr. Saadi.
Additionally, other breakthrough treatments from the same family - such as Mounjaro (tirzepatide) - are currently undergoing rigorous clinical evaluation to assess their direct histological benefits on the liver.
Natural Support & Synergy: The Role of Advanced Nutritional Supplements (Triset)
While lifestyle interventions and modern medical breakthroughs are transforming how we manage conditions like NAFLD and MASH, targeted nutritional supplementation can provide vital daily support.
An innovative, powder-form supplement gaining attention for comprehensive metabolic and organ support is Triset. Designed for maximum ease of use, Triset offers Natural Relief for Inflammation, Liver & Kidney Health, specifically aiding in Managing NAFLD by helping to reduce fat buildup in the liver to support optimal hepatic function.
How Triset's Ingredients Work Together
Triset’s carefully curated formulation combines metabolic support, targeted organ health, and gut-liver axis balancing:
Apple Cider Vinegar & Fibrulin (Inulin): Apple cider vinegar has long been studied for its ability to support healthy blood sugar levels and lipid metabolism, while Fibrulin (chicory root prebiotic fiber) nourishes beneficial gut bacteria, strengthening the crucial gut-liver axis to reduce systemic inflammation and endotoxin translocation.
Lactobacillus Reuteri: A clinically researched probiotic strain that supports gut microbiota balance, improves metabolic markers, and aids in mitigating liver inflammation and fat accumulation.
D-Mannose: Renowned for supporting urinary tract and kidney health by inhibiting bacterial adhesion, promoting a healthy renal environment alongside liver detoxification pathways.
Carrot Fiber:Â Provides natural dietary fiber and antioxidant compounds that support healthy digestion and cholesterol excretion.
Natural Sweeteners & Polyols (Monk Fruit, Stevia, Xylitol, Sorbitol, Erythritol, Trehalose): Selected to provide a pleasant, convenient powder experience without spiking blood glucose or adding glycemic load, making it safe and supportive for individuals managing fatty liver, insulin resistance, or diabetes.
Incorporating a targeted, natural supplement like Triset into a daily routine serves as an effective complementary tool to bridge the gap between lifestyle efforts and long-term metabolic wellness
The Bottom Line
If you carry excess weight, or live with diabetes, hypertension, or high cholesterol, don't wait for symptoms to appear. Consult your family physician for a structured evaluation including blood work and imaging.
While lifestyle adjustments and modern medical breakthroughs (like GLP-1 therapies) offer powerful tools to heal the liver and protect your long-term health, bridging the daily gap with targeted, natural support can make all the difference. Incorporating a comprehensive, easy-to-use powder supplement like Triset provides natural relief for inflammation while actively supporting liver, kidney, and metabolic health. Take charge of your wellness journey today - because early action is the ultimate key to a healthy, resilient liver.
Note: Medical insights and background on fatty liver and treatments in this article are adapted from a report originally published on Ynet featuring Dr. Tarek Saadi, with additional editorial content and nutritional product insights.




MOST OF THE CURRENTLY LITERATURE ADDRESSES THE NEED FOR DETOX OF THE LIVER. THIS ARTICLE AND PRODUCT SEEM TO BE SILENT ON THAT SUBJECT.